(Q34424877)

2 August 2017

1 reference

title

Budesonide for chronic asthma in children and adults (English)

1 reference

2 August 2017

1 reference

2

J Bestall

1 reference

2 August 2017

N Adams

1

1 reference

PubMed ID

11687183

2 August 2017

P W Jones

series ordinal

3

1 reference

2 August 2017

1 January 2001

1 reference

Cochrane Database of Systematic Reviews

2 August 2017

1 reference

2 August 2017

4

1 reference

2 August 2017

CD003274

1 reference

Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study.

2 August 2017

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Relative effects of inhaled corticosteroids on immunopathology and physiology in asthma: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

The effect of two months of treatment with inhaled budesonide on bronchial responsiveness to histamine and house-dust mite antigen in asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Effects of 22 months of treatment with inhaled corticosteroids and/or beta-2-agonists on lung function, airway responsiveness, and symptoms in children with asthma. The Dutch Chronic Non-specific Lung Disease Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Action of budesonide on asthmatic bronchial hyperresponsiveness. Effects on directly and indirectly acting bronchoconstrictors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Controlled trial of budesonide given by the nebuhaler in preschool children with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Effect of budesonide on pulmonary hyperinflation in young asthmatic children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Use of inhaled corticosteroids in patients with mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Effect of 1 year daily treatment with 400 microg budesonide (Pulmicort Turbuhaler) in newly diagnosed asthmatics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Inhaled budesonide reduces lung hyperinflation in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

A study of the mechanism of the antiasthmatic action of inhaled budesonide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Effect of inhaled budesonide on bronchial reactivity to histamine, exercise, and eucapnic dry air hyperventilation in patients with asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Effects of budesonide and bambuterol on circadian variation of airway responsiveness and nocturnal symptoms of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Inhaled budesonide for treatment of recurrent wheezing in early childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Evaluation of corticotropin releasing factor stimulation and basal markers of hypothalamic-pituitary-adrenal axis suppression in asthmatic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Use of budesonide in severe asthmatics aged 1-3 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Calculation of knemometric growth rates in group studies of children treated with exogenous glucocorticoids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Treatment of severe steroid dependent preschool asthma with nebulised budesonide suspension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Inhaled budesonide for chronic wheezing under 18 months of age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Effect of continuous treatment with topical corticosteroid on episodic viral wheeze in preschool children

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Dose-response comparison of systemic bioactivity with inhaled budesonide and triamcinolone acetonide in asthmatic adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Differential effects of inhaled budesonide on serum osteocalcin in children and adolescents with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Effect of an inhaled glucocorticosteroid on mast cell and smooth muscle beta 2 adrenergic tolerance in mild asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

Systemic activity of inhaled topical steroid in toddlers studied by knemometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003274

10.1002/14651858.CD003274

21 January 2018

Identifiers

DOI

1 reference

2 August 2017

1 reference

PubMed ID

11687183